Location History:
- Aachen, DE (2006)
- Roetgen, DE (2011)
Company Filing History:
Years Active: 2006-2011
Title: Clemens Gillen: Innovator in Nucleic Acids and Cyclopentene Compounds
Introduction
Clemens Gillen is a notable inventor based in Roetgen, Germany. He has made significant contributions to the fields of nucleic acids and pharmaceutical compounds. With a total of 2 patents, his work has implications for medical advancements.
Latest Patents
Gillen's latest patents include innovations in CGRP binding nucleic acids and substituted cyclopentene compounds. The first patent relates to an antagonist for CGRP and amylin, where the antagonist is a nucleic acid that binds to CGRP or amylin. This nucleic acid preferably comprises an L-nucleotide. The second patent focuses on substituted cyclopentene compounds, detailing a process for their production, pharmaceutical preparations containing these compounds, and their use in creating pharmaceutical products.
Career Highlights
Throughout his career, Clemens Gillen has worked with prominent companies such as Noxxon Pharma AG and Grünenthal GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Gillen has collaborated with notable colleagues, including Gregor Bahrenberg and Klaus Schiene. These partnerships have contributed to the advancement of his research and inventions.
Conclusion
Clemens Gillen's work in the field of nucleic acids and pharmaceutical compounds showcases his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to developing new solutions for health-related challenges.